Resonance Health Limited (ASX:RHT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0400
0.00 (0.00%)
At close: Mar 6, 2026
-6.98%
Market Cap 19.08M
Revenue (ttm) 13.84M
Net Income (ttm) 769.30K
Shares Out 477.12M
EPS (ttm) 0.00
PE Ratio 24.59
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 383,037
Average Volume 398,317
Open 0.0400
Previous Close 0.0400
Day's Range 0.0400 - 0.0400
52-Week Range 0.0330 - 0.0590
Beta 1.12
RSI 43.84
Earnings Date Feb 26, 2026

About Resonance Health

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-bas... [Read more]

Sector Healthcare
Founded 1987
Employees 16
Stock Exchange Australian Securities Exchange
Ticker Symbol RHT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.